(Q43813648)

27 November 2017

title

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. (English)

1 reference

27 November 2017

S Orengo-Nania

1

1 reference

27 November 2017

T Landry

2

1 reference

27 November 2017

M Von Tress

3

1 reference

27 November 2017

L H Silver

4

1 reference

27 November 2017

A Weiner

5

1 reference

27 November 2017

A A Davis

6

1 reference

27 November 2017

Travoprost Study Group

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

American Journal of Ophthalmology

27 November 2017

published in

1 reference

27 November 2017

volume

132

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

860-868

1 reference

Association between intraocular pressure and loss of visual field in chronic simple glaucoma

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Intraocular pressure and glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

[3H]AL-5848 ([3H]9beta-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

The mechanism of action of prostaglandins on uveoscleral outflow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Effects of topical epinephrine on aqueous humor dynamics in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

Fluorophotometric study of epinephrine and timolol in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901257-0

10.1016/S0002-9394(01)01257-0

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference